HomePYXS • NASDAQ
add
Pyxis Oncology Inc
Previous close
$1.11
Day range
$1.10 - $1.21
Year range
$0.84 - $5.39
Market cap
74.96M USD
Avg Volume
526.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.40M | 9.39% |
Net income | -21.16M | -549.82% |
Net profit margin | — | — |
Earnings per share | -0.35 | -483.33% |
EBITDA | -21.85M | -492.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 105.43M | -32.86% |
Total assets | 135.87M | -38.30% |
Total liabilities | 32.76M | -9.15% |
Total equity | 103.10M | — |
Shares outstanding | 61.95M | — |
Price to book | 0.66 | — |
Return on assets | -38.22% | — |
Return on capital | -42.44% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -21.16M | -549.82% |
Cash from operations | -22.54M | -8.81% |
Cash from investing | 15.82M | 185.53% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -6.71M | -136.68% |
Free cash flow | -14.05M | 27.02% |
About
Founded
2018
Headquarters
Website
Employees
44
